NRX Pharmaceuticals (NRXP)

• Market cap: $72.2M
• 1 day: 2.09%
• 5 days: 0%
• 1 month: 8.93%
• 3 months: -18.39%
• 6 months: -24.22%
• Year to date: -18.39%
• 1 year: 55.41%
• 5 years: -99.18%
• 10 years: -97.46%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.